July 4th 2025

By Ailsa Colquhoun

Tadalafil and vardenafil SLS proposals

The DDA has been consulted on proposals to remove erectile dysfunction medications tadalafil and vardenafil from the SLS.

Both medications are widely available as generics and removing SLS restrictions will benefit patients who do not tolerate sildenafil.

In addition, the Department proposes adding Cialis and Levitra to the SLS, due to the comparatively higher cost of branded medicines.

The DDA has no objections to the proposals which widen the options for men already seeking treatment for this condition.

Clinical guidance news England

Latest news

DDA podcast looks at private weight loss clinics

Oral orforglipron GLP1 (marketed in the USA by Lilly as Foundayo) was authorised for use in weight management and type 2 diabetes in August 2026, in a UK first. In this new DDA podcast, the 12th in our series, DDA Communications Officer Ailsa Colquh

DDA raises rural GP issues in Westminster event

DDA Board Member Dr Ian Hume raised the rural challenges facing dispensing GPs in a Rebuild General Practice campaign roundtable with Liberal Democrat MPs.The discussion focused on the challenges facing GP practices across the country, from rising de

MSN: lansoprazole 15mg and 30mg orodispersible tablets

DHSC has published a Tier 2 Medicine Supply Notification (MSN) for lansoprazole 15mg and 30mg orodispersible tablets: limited supply until early January 2027. Up-to-date information abour medicine supply issues can be found in the DHSC and NHSE

View all news

DDA Suppliers Directory

Follow us

ad1

Dispensing Doctors' Association

Follow us

ad1

DDA Best Practice Group

Follow us

ad1

Dispensing Doctors' Association

Follow @TheDDA1 on X